Two-Year Outcomes After Variable Duration of Drug Cessation in Patients With Maculopathy Associated With Pentosan Polysulfate Use.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2022.6093
Abstract: Importance Prior retrospective studies have provided limited evidence on disease progression following drug cessation in patients with maculopathy associated with pentosan polysulfate (PPS). Objective To evaluate the 2-year evolution of maculopathy associated with PPS use… read more here.
Keywords: maculopathy associated; iqr; year; drug cessation ... See more keywords